Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03456063 |
|---|---|
| Brief Title: | A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) |
| First Submitted : | March 5, 2018 |
| First Submitted that Met QC Criteria : | March 5, 2018 |
| First Posted : | March 7, 2018 |
| Last Update Submitted that Met QC Criteria : | March 14, 2022 |
| Last Update Posted : | March 29, 2022 |